Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden · Delayed Price · Currency is SEK 191.00
-2.70 (-1.39%)
At close: Feb 10, 2026
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 6.1 billion as of February 10, 2026. Its market cap has decreased by -53.55% in one year.
Market Cap
6.10B
Enterprise Value
5.93B
Revenue
812.17M
Ranking
n/a
PE Ratio
242.48
Stock Price
191.00
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 6.10B, an increase of 1,541.53%. That is a compound annual growth rate of 23.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 6.10B | 3.80% |
| Dec 30, 2025 | 5.88B | -61.84% |
| Dec 30, 2024 | 15.40B | 48.41% |
| Dec 29, 2023 | 10.38B | 90.12% |
| Dec 30, 2022 | 5.46B | -33.55% |
| Dec 30, 2021 | 8.22B | -8.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sectra AB | 40.19B |
| Elekta AB | 21.17B |
| Nolato AB | 13.99B |
| Vitrolife AB | 12.30B |
| MedCap AB | 8.20B |
| CellaVision AB | 3.89B |
| BICO Group AB | 1.23B |
| C-Rad AB | 1.06B |